Lydia Fennessy
AHN Cancer Institute-Med Onc & Infusions at Allegheny Valley Hospital
Office (724) 226-7105
Fax (724) 226-7106
1301 Carlisle Street,
Natrona Heights, PA 15065
About
Lydia Fennessy
Lydia Fennessy, PA-C, is a physician assistant specializing in hematology and medical oncology. She has a clinical focus on the care and treatment of patients with breast cancer, colon cancer, melanoma, and benign hematologic conditions. Lydia earned both her Bachelor of Science in Health Science and her Master of Physician Assistant Studies from Gannon University in Erie, Pennsylvania. She is certified by the National Commission on Certification of Physician Assistants and is a member of the American Academy of Physician Associates. Lydia is passionate about patient education, ensuring her patients feel informed and supported throughout their care journey. She welcomes patients ages 18 and older.
Primary Specialty
Oncologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny Valley Hospital
Gender
Female
Education
Gannon University
Certification
National Commission on Certification of Physician Assistants--
Not Accepting New Patients
Degrees
Physician Assistant Certified
Admitting Hospitals
Allegheny Valley Hospital, West Penn Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Allegheny Valley Hospital
Languages
English
Business Hours
Monday:8:00 AM - 4:00 PM
Tuesday:8:00 AM - 4:00 PM
Wednesday:8:00 AM - 4:00 PM
Thursday:8:00 AM - 4:00 PM
Friday:8:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, nut carcinoma, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), adolescent and young adult cancer (aya), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, metastatic breast cancer, hodgkin lymphoma, triple negative breast cancer, cancer genetics, hemoglobinopathies, breast cancer therapy, thrombocytosis, castleman's disease, acute blood loss anemia, blood disorders, lymphopenia, prostate cancer, early detection of cancer, von willebrand disease, adenocarcinoma of lung, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, breast cancer, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, recurrent cervical cancer, squamous cancer of the lung, esophageal cancer, kasabach merritt phenomenon (kmp), anemia of chronic disease